Top Medtronic executive enlisted in healthcare reform group

November 11, 2010 by MedCity News

Medtronic senior executive Dr. Richard Kuntz named to board of governors of the Patient-Centered Outcomes Research Institute.

MedCity News logo

Medtronic Inc. (NYSE:MDT) has long viewed comparative effectiveness research with a wary eye.

While publicly supporting the goals of lowering healthcare costs, the company fears CER — the idea that the government should pay only for treatments that compare favorably to other therapies — could shut out certain medical devices.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.